BRCA1

23andMe’s New BRCA1/BRCA2 Report

April 11, 2018
23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.
Read More

A Major Milestone in Consumer Health Empowerment

March 06, 2018
23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report. The report covers three variants in the BRCA1 and BRCA2 genes associated with increased risk for breast, ovarian, and prostate cancer.
Read More

Talking About Breast Cancer Risk

May 14, 2013
Angelina Jolie’s revelation in the New York Times today that she had a double mastectomy after learning about her genetic risk for breast cancer focused attention on the difficult dilemma...
Read More

Customer response to direct-access BRCA genetic testing

February 12, 2013
We know from scientific research that, in general, people don’t freak out about the results they get from personal genetic testing. When the results show an increased risk for serious...
Read More

Investigating the Rare

November 01, 2012
(Editor’s note: Here is a link to Brian’s poster presented at ASHG.) Rare events are hard to study, and this is especially true in genetics. Imagine you have a group...
Read More